Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial.

Kaplan SA, Roehrborn CG, McConnell JD, Meehan AG, Surynawanshi S, Lee JY, Rotonda J, Kusek JW, Nyberg LM Jr; Medical Therapy of Prostatic Symptoms Research Group.

J Urol. 2008 Sep;180(3):1030-2; discussion 1032-3. doi: 10.1016/j.juro.2008.05.004. Epub 2008 Jul 17.

PMID:
18639298
2.

The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia.

Johnson TM 2nd, Burrows PK, Kusek JW, Nyberg LM, Tenover JL, Lepor H, Roehrborn CG; Medical Therapy of Prostatic Symptoms Research Group.

J Urol. 2007 Nov;178(5):2045-50; discussion 2050-1. Epub 2007 Sep 17.

PMID:
17869295
3.

Long-term treatment with finasteride improves clinical progression of benign prostatic hyperplasia in men with an enlarged versus a smaller prostate: data from the MTOPS trial.

Kaplan SA, Lee JY, Meehan AG, Kusek JW; MTOPS Research Group.

J Urol. 2011 Apr;185(4):1369-73. doi: 10.1016/j.juro.2010.11.060. Epub 2011 Feb 22.

4.

Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater.

Kaplan SA, McConnell JD, Roehrborn CG, Meehan AG, Lee MW, Noble WR, Kusek JW, Nyberg LM Jr; Medical Therapy of Prostatic Symptoms (MTOPS) Research Group.

J Urol. 2006 Jan;175(1):217-20; discussion 220-1.

PMID:
16406915
5.

Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.

Fwu CW, Eggers PW, Kirkali Z, McVary KT, Burrows PK, Kusek JW.

J Urol. 2014 Jun;191(6):1828-34. doi: 10.1016/j.juro.2013.12.014. Epub 2013 Dec 14.

PMID:
24342143
6.

Finasteride for benign prostatic hyperplasia.

Tacklind J, Fink HA, Macdonald R, Rutks I, Wilt TJ.

Cochrane Database Syst Rev. 2010 Oct 6;(10):CD006015. doi: 10.1002/14651858.CD006015.pub3. Review.

PMID:
20927745
7.

Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.

Logan YT, Belgeri MT.

Am J Geriatr Pharmacother. 2005 Jun;3(2):103-14. Review.

PMID:
16129387
8.

Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial.

Kirby RS, Roehrborn C, Boyle P, Bartsch G, Jardin A, Cary MM, Sweeney M, Grossman EB; Prospective European Doxazosin and Combination Therapy Study Investigators.

Urology. 2003 Jan;61(1):119-26.

PMID:
12559281
9.

Finasteride and doxazosin alone or in combination for the treatment of benign prostatic hyperplasia.

Bhardwa J, Goldstraw M, Tzortzis S, Kirby R.

Expert Opin Pharmacother. 2007 Jun;8(9):1337-44. Review.

PMID:
17563267
10.

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.

McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg LM Jr, Clarke HS, Crawford ED, Diokno A, Foley JP, Foster HE, Jacobs SC, Kaplan SA, Kreder KJ, Lieber MM, Lucia MS, Miller GJ, Menon M, Milam DF, Ramsdell JW, Schenkman NS, Slawin KM, Smith JA; Medical Therapy of Prostatic Symptoms (MTOPS) Research Group.

N Engl J Med. 2003 Dec 18;349(25):2387-98.

11.

An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.

McDonald H, Hux M, Brisson M, Bernard L, Nickel JC.

Can J Urol. 2004 Aug;11(4):2327-40.

PMID:
15380054
13.

Long-term effects of doxazosin, finasteride and combination therapy on quality of life in men with benign prostatic hyperplasia.

Fwu CW, Eggers PW, Kaplan SA, Kirkali Z, Lee JY, Kusek JW.

J Urol. 2013 Jul;190(1):187-93. doi: 10.1016/j.juro.2013.01.061. Epub 2013 Jan 25.

PMID:
23357210
14.

5alpha-reductase inhibitors: what role should they play?

Kaplan SA.

Urology. 2001 Dec;58(6 Suppl 1):65-70; discussion 70. Review.

PMID:
11750255
15.

[Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].

Hausmann R, Thalmann G, Reich O, Steif CG.

Aktuelle Urol. 2004 Sep;35(5):339-42. German. No abstract available.

PMID:
15383991
16.

Doxazosin in the treatment of benign prostatic hypertrophy: an update.

Wilt TJ, MacDonald R.

Clin Interv Aging. 2006;1(4):389-401. Review.

19.

[Benign prostatic syndrome. 3-step plan for the treatment].

[No authors listed]

MMW Fortschr Med. 2003 Sep 25;145(39):52. German. No abstract available.

PMID:
14649077

Supplemental Content

Support Center